Close

Explore AI

Explore GPTs

Explore AI News

Explore AI Videos

Explore AI for Jobs

Latest Regeneron AI Videos

Find the latest for Regeneron company videos

Follow
... 10:2
Palantir’s AI Dominance—Cathie Wood Says It’s Just Getting Started! Hedge Funds Are Piling Into PLTR

YT Finance

1+ months ago 1K views

Paler Technologies stands at the forefront of AI and data analytics, integrating cutting-edge solutions for enterprise and government operations. An exclusive event highlighted real-world case studies showcasing substantial returns on investment for clients. Despite its strong financial performance and recognition, concerns remain about high stock valuations, with analysts questioning the sustainability of its rapid growth. Key investor Kathy Wood from Arc Investment Management continues to express confidence in Paler's long-term potential amidst varying opinions on its current valuation and market strategy as it prepares for significant expansion in 2025.
05:48 - 05:53

Paler anticipates the widespread adoption of AI technology as a strategic advantage.

Palantir Big Data Analytics Finance
... 4:31
Google Researchers Announce an AI Co-Scientist

Bloomberg Technology

1+ months ago 1K views

A generative AI system enables scientists to enhance their research productivity by generating and evolving hypotheses over a weekend. This multi-agent model creates diverse ideas, which are refined and improved through competition and experience. Collaborations, such as with Imperial College, demonstrate how the system can expedite research processes, achieving results quicker than traditional methods. Despite some skepticism in the scientific community, the system aims to complement rather than replace scientists, enhancing their ability to generate ideas and delve into research more effectively.
02:33 - 02:57

Supplementing generative AI with checklists improves accuracy and reliability in research.

Google Machine Learning Healthcare
... 14:23
𝗨𝗦𝗔 𝟮𝟬𝟮𝟱 👉 AI Made From HUMAN BLOOD Miry Clay Cleaved To Iron - #2025 #RFB

Richie From Boston - FanPage

1+ months ago 3K views

The CL1 computer represents a breakthrough in AI, merging biological neurons from human stem cells with silicon technology to create a new form of synthetic biological intelligence. This innovative system learns rapidly and adapts more effectively than traditional silicon-based AI while consuming less energy. The technology could transform drug testing and personalized medicine by utilizing patient-derived neurons. However, the development raises ethical concerns regarding its source of biological material and its ramifications for society and human health.
03:53 - 04:05

Prediction of the CL1's impact on drug discovery and overall medical advancements.

Melbourne start-up AI hardware Research & Innovations
... 18:9
Elon Musk's 2025 Optimus Gen 3: INSANE Nursing Robot with AI, Grok 3. LATEST REVEALS!

ADAM TECH

1+ months ago 1K views

Optimus Gen 3 is presented as a groundbreaking humanoid robot equipped for caregiving applications, emphasizing its advanced AI and robotic capabilities. It highlights significant improvements over previous models, including enhanced dexterity and real-time health monitoring, enabling it to function effectively in home healthcare settings. The robot's integration with Grock 3 AI facilitates adaptability and safety, positioning it as a reliable companion for elderly care. Optimus Gen 3 is set to enter low-volume production by 2025, with plans for wider deployment aimed at addressing caregiver shortages and providing superior nursing support.
03:39 - 03:53

Grock 3 AI enhances Optimus Gen 3's decision-making capabilities.

Tesla Robotics Healthcare
... 9:26
The Role of AI in Personalized Medicine Tailoring Treatments for Every Patient

The Transforming Treatment Institute

1+ months ago 3K views

Personalized medicine, driven by advanced AI technologies, transforms healthcare by tailoring treatments to individual genetic profiles and environmental factors. This approach moves beyond one-size-fits-all practices, enabling predictive analytics for conditions such as heart disease and cancer. AI's power in genomics allows for faster and cheaper sequencing of DNA, assisting in early diagnosis and customized treatment plans. Future advancements promise a shift from reactive to proactive healthcare, empowering patients and doctors alike through continuous data monitoring and tailored interventions, ultimately enhancing survival rates and improving overall health outcomes.
02:38 - 02:42

Genomic profiling with AI identifies mutations for targeted cancer therapies.

Machine Learning Healthcare
... 13:50
IDOLpro: Generative AI for Chemistry | Tech talk with Amit Kadan

SandboxAQ

1+ months ago 2K views

IDOLpro combines AI and physics to enhance drug design by generating small molecules tailored for specific protein targets. Traditional methods are time-consuming, as they require evaluating vast chemical libraries. In contrast, IDOLpro uses generative AI to jump directly to relevant chemical spaces, optimizing for properties like synthetic accessibility and binding affinity. The framework employs a diffusion model guided by machine learning and physics-based scoring functions, significantly improving the efficiency of drug discovery. Initial evaluations show IDOLpro outperformed existing methods in generating viable drug candidates with desirable properties.
04:00 - 04:04

Iterative grading in IDOLpro enhances molecular properties like binding affinity.

SandboxAQ Machine Learning Research & Innovations
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance
... 22:14
This new AI finds REAL cancer cures & life-saving drugs

AI Search

1+ months ago 22K views

Google's new AI Co-Scientist has achieved significant breakthroughs in drug discovery, including new treatments for leukemia and liver disease, both validated in real-life experiments. This AI system, built with Gemini 2.0, assists scientists by generating novel hypotheses and research proposals, accelerating scientific discoveries. It collaboratively works with human scientists, providing original ideas for complex problems. The AI has demonstrated its capabilities by tackling issues like antibiotic resistance, suggesting candidates quickly compared to traditional research timelines, marking a transformative leap in biomedical research through advanced computational methods.
03:30 - 05:30

AI identifies new targets for liver fibrosis, demonstrating real-world efficacy.

Google Machine Learning Healthcare
... 22:14
This new AI finds REAL cancer cures & life-saving drugs

AI Search

1+ months ago 22K views

Google's new AI Co-Scientist has achieved significant breakthroughs in drug discovery, including new treatments for leukemia and liver disease, both validated in real-life experiments. This AI system, built with Gemini 2.0, assists scientists by generating novel hypotheses and research proposals, accelerating scientific discoveries. It collaboratively works with human scientists, providing original ideas for complex problems. The AI has demonstrated its capabilities by tackling issues like antibiotic resistance, suggesting candidates quickly compared to traditional research timelines, marking a transformative leap in biomedical research through advanced computational methods.
03:30 - 05:30

AI identifies new targets for liver fibrosis, demonstrating real-world efficacy.

Google Machine Learning Healthcare